Organon and Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's g
In one of the biggest outbound acquisitions ever attempted by an Indian company, Sun Pharmaceutical Industries has decided to buy Organon & Co. for $14 a share in an all-cash deal valued at $11.8 bill
Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of Organ
Sun Pharma has offered to pay $14.00 a share in an all-cash deal.
Sun Pharmaceutical ​Industries ‌will acquire Organon & ​Co ​in an ⁠all‑cash ​deal, ​valuing the U.S. drugmaker ​at ​about $11.75 billion, ‌the ⁠companies said in a ​joint ​
MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or asso
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Organon (OGN) Rises Higher Than Market: Key Facts

06:51pm, Thursday, 16'th Apr 2026
The latest trading day saw Organon (OGN) settling at $9.33, representing a +1.3% change from its previous close.
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon will release its first quarter 2026 financial results and host conference call on May 7, 2026.
JERSEY CITY, N.J.--(BUSINESS WIRE)--VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.
In the latest trading session, Organon (OGN) closed at $8.54, marking a -3.28% move from the previous day.
An index measuring market sentiment based on fear and greed showed a slight increase in fear levels on Friday.
Shares of Organon (OGN) surged sharply on Friday after a report indicated that Sun Pharmaceutical Industries had submitted a binding $12 billion all-cash offer
Citing people familiar with the matter, the Economic Times reported that Sun Pharma has completed an extensive due diligence process spanning more than three months.
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE